Abstract
Nitric oxide was recognized fifteen years ago to be an endothelium-dependent relaxing factor with an important role in vasomotor control through its actions on vascular smooth muscle (1). Shortly after this discovery it was also demonstrated that nitric oxide (NO) is an inhibitor of platelet function and plays a physiological role in the reduction in platelet activation (2). This is achieved because platelets while circulating, being the smallest of the blood cells, are closest to the endothelium, which is considered to be the most important source of NO in the vasculature. However, it was soon realized that platelets themselves are capable of biosynthesising NO when they are activated (3).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Palmer, R. M. J, Ferridge, A. G, and Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (London) 327, 524–526.
Radomski, M. W., Palmer, R. M., and Moncada, S. (1987) Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2, 1057–1058.
Radomski, M. W., Palmer, R. M. J., and Moncada, S. (1990) Characterization of the L-arginine:nitric oxide pathway in human platelets. Br. J. Pharmacol. 101, 325–328.
Palmer, R. M. J, Ashton, D. S., and Moncada, S. (1988) Vascular endothelial cells biosyn-thesise nitric oxide from L-arginine. Nature (London) 333, 664–666.
Alderton, W. K., Cooper, C. E., and Knowles, R. G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593–615.
Freedman, J. E., Loscalzo, J., Barnard, M. R., Alpert, C., Keaney, J. F., and Michelson, A. D. (1997) Nitric oxide released from activated platelets inhibits platelet recruitment. J. Clin. Invest. 100, 350–356.
Anfossi, G., Russo, I., Massucco, P., Mattiello, L., Cavalot, F., Balbo, A., et al. (2002) Adenosine increases human platelet levels of cGMP through nitric oxide—possible role in its antiaggregating effect. Thromb. Res. 105, 71–78.
Anfossi, G., Russo, I., Massucco, P., Mattiello, L., and Trovati, M. (2002) Catecholamines, via β-adrenoreceptors, increase intracellular concentrations of 3′,5′-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. Thromb. Haemost. 87, 539–540.
Ignarro, L. J. (1989) Heme-dependent activation of soluble guanylate cyclase by nitric oxide: regulation of enzyme activity by porphyrins and metalloporphyrins. Seminars in Haematol. 26, 63–76.
Wedel, B., Harteneck, C., Foerster, J., Friebe, A., Schultz, A., Schultz, G., et al. (1995) Functional domains of soluble guanylyl cyclase. J. Biol. Chem. 270, 24,871–24,875.
Friebe, A., Schultz, G., and Koesling, D. (1998) Sensitizing soluble guanylyl cyclase to become a highly co-sensitive enzyme. EMBO J. 15, 6863–6868.
Halbrugge, M., Friedrich, C., Eigenthaler, M., Schanzenbacher, P., and Walter, U. (1990) Stoichiometric and reversible phosphorylation of 46 kDa protein in human platelets in response to cGMP and cAMP elevation. J. Biol. Chem. 265, 3088–3093.
Prehoda, K. E., Lee, D. H., and Lim, W. A. (1999) Structure of the Enabled/VASP homology 1 domain—peptide complex: a key componenet in the spatial control of actin assembly. Cell 97, 471–480.
Aszodi, A., Pfeifer, A., Ahmad, M., Glauner, M., Zhou, X.-H., Ny, L., et al. (1999) The vasodilator-stimulated phosphoprotein is involved in cGMP and cAMP-mediated inhibition of agonist induced platelet aggregation, but is dispensable for smooth muscle function EMBO J. 18, 37–48.
Stamler, J. S., Lamas, S., and Fang, F. C. (2001) Nitrosylation: the prototypic redox-based signaling mechanism. Cell 106, 675–683.
Liu, L., Hausladen, A., Zeng, M., Que, L., Heitman, J., and Stamler, J. S. (2001) A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410, 490–494.
Hiriyama, A., Noronha-Dutra, A. A., Gordge, M. P., Neild, G. H., and Hothersall, J. S. (1999) S-nitrosothiols are stored by platelets and released during platelet-neutrophil interactions. Nitric Oxide: Biology and Chemistry 3, 95–104.
Waldron, G. J. and Cole, W. C. (1999) Activation of vascular smooth muscle K+ channels by endothelium-derived relaxing factors. Clin. Pharm. and Physiol. 26, 180–184.
Freedman, J. E., Frei, B., Welch, G. N., and Loscalzo, J. (1995) Glutathione peroxidase potentiates the inhibition of platelet function by S-nitrosothiols. J. Clin. Invest. 96, 394–400.
Vargas, J. R., Radomski, M., Moncada, S. (1982) The use of prostaglandin in the separation from plasma and washing of human platelets. Prostaglandins 23, 929–945.
Naseem, K. M. and Bruckdorfer, K. R. (1995) Hydrogen peroxide at low concentrations strongly enhances the inhibitory effect of nitric oxide on platelets. Biochem. J. 310, 149–153.
Riddell, D. R., Graham, A., and Owen, J. S. (1997) Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. J. Biol. Chem. 272, 89–95.
Wang, G. R., Zhu, Y., Halushka, P. V., Lincoln, T. M., and Mendelsohn, M. E. (1998) Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic-GMP dependent protein kinase. Proc. Natl. Acad. Sci. USA 95, 4888–4893.
Butt, E., ImmLer, D., Meyer, H. E., Kotlyarov, A., Laass, K., and Gaestel, M. (2001) Heat shock protein 27 is a substrate of cyclic GMP-dependent kinase in intact human platelets. J. Biol. Chem. 276, 7108–7113.
Sawada, N., Itoh, H., Yamashita, J., Doi, K., Inoue, M., Masatasugu, K., et al. (2001) cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys. Res. Comm. 280, 798–805.
Colbran, J. L., Francis, S. H., Leach, A. B., Thomas, M. K., Jiang, H., McAllister, L. M., et al. (1992) A phenylalanine in peptide substrates provides for selectivity between cGMP and cAMP-dependent protein kinases. J. Biol. Chem. 287, 9589–9594.
Burkhard, M., Glazova, M., Gambaryan, S., Vollkommer, T., Butt, E., Bader, B., et al. (2000) KT5823 inhibits cGMP-dependent protein kinase activity in vitro but not in intact human platelets and rat mesangial cells. J. Biol. Chem. 275, 33,536–33,541.
Marley, R., Patel, R. P., Orie, N., Ceaser, E., Darley-Usmar, V., and Moore, K. P. (2001) Formation of nanomolar concentrations of S-nitroso-albumin in human plasma by nitric oxide. Free Radical Biology and Medicine 31, 688–696.
Humbert, P., Niroomand, F., Fischer, G., Mayer, B., Koesling, D., Hinsch, K. D., et al. (1990) Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur. J. Biochem. 190, 273–278.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Low, S.Y., Bruckdorfer, K.R. (2004). Nitric Oxide Signaling in Platelets. In: Gibbins, J.M., Mahaut-Smith, M.P. (eds) Platelets and Megakaryocytes. Methods in Molecular Biology™, vol 273. Humana Press. https://doi.org/10.1385/1-59259-783-1:313
Download citation
DOI: https://doi.org/10.1385/1-59259-783-1:313
Publisher Name: Humana Press
Print ISBN: 978-1-58829-011-3
Online ISBN: 978-1-59259-783-3
eBook Packages: Springer Protocols